Open original FDA record ↗Recall record
- FDA identifier
- Z-1855-2014
- Company in FDA record
- NxStage Medical, Inc.
- FDA classification date
- Jun 24, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
SAK Dialysate Concentrate contain aluminum levels which exceed internal product specification
Source facts
- Action
- NxStage issued Initial recall letter dated 5/14/14 to dialysis centers. An error was noted and an updated letter dated 5/15/14 was resent to dialysis centers. The updated 5/15/14 letter was emailed to all current active PureFlow SL patients who had provided an email address followed by UPS next business day letter sent to all current active PureFlow SL patients. Accounts are requested to examine inventory and remove product. Contact NxStage Customer Service to arrange for return of all affected product and for replacement product to be sent. If you have any questions or comments, please feel free to contact NxStage Customer Service at 1-866-NXSTAGE (1-866-697-8243).
- Initiated
- 2014-05-14
- Root cause
- Material/Component Contamination
- Terminated
- 2017-03-13
- Distribution
- Worldwide Distribution - USA (nationwide) and Internationally to France, Netherlands, Spain, Sweden, and the UK.
- Recall number
- Z-1855-2014
- Recall status
- Terminated
- CDRH record ID
- 127451
- FDA classified
- 2014-06-24
- Recall event number
- 68354